Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1974 1
1975 1
1994 1
1996 2
1997 1
1998 1
2000 1
2004 1
2008 1
2015 1
2016 1
2017 2
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.
Garcia-Aymerich J, Puhan MA, Corriol-Rohou S, de Jong C, Demeyer H, Dobbels F, Erzen D, Frei A, Gimeno-Santos E, Hopkinson NS, Ivanoff N, Karlsson N, Louvaris Z, Polkey MI, Rabinovich RA, Scuri M, Tabberer M, Vogiatzis I, Troosters T; PROactive consortium. Garcia-Aymerich J, et al. Among authors: ivanoff n. Thorax. 2021 Mar;76(3):228-238. doi: 10.1136/thoraxjnl-2020-214554. Epub 2021 Jan 21. Thorax. 2021. PMID: 33479044 Free PMC article.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Alavi A, Prens E, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao H, Ranganathan U, Ivanoff NB, Hernandez Daly AC, Zouboulis CC. Alavi A, et al. Among authors: ivanoff nb. Br J Dermatol. 2024 Apr 5:ljae144. doi: 10.1093/bjd/ljae144. Online ahead of print. Br J Dermatol. 2024. PMID: 38576350
The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease.
Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagaña X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium. Gimeno-Santos E, et al. Among authors: ivanoff n. Eur Respir J. 2015 Oct;46(4):988-1000. doi: 10.1183/09031936.00183014. Epub 2015 May 28. Eur Respir J. 2015. PMID: 26022965 Free PMC article. Clinical Trial.
Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.
Stockfleth E, von Kiedrowski R, Dominicus R, Ryan J, Ellery A, Falqués M, Ivanoff N, Azeredo RR. Stockfleth E, et al. Among authors: ivanoff n. Dermatol Ther (Heidelb). 2017 Mar;7(1):81-96. doi: 10.1007/s13555-016-0161-2. Epub 2016 Dec 19. Dermatol Ther (Heidelb). 2017. PMID: 27995485 Free PMC article.
Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.
Stockfleth E, von Kiedrowski R, Dominicus R, Ryan J, Ellery A, Falqués M, Ivanoff N, Azeredo RR. Stockfleth E, et al. Among authors: ivanoff n. Dermatol Ther (Heidelb). 2017 Jun;7(2):263. doi: 10.1007/s13555-017-0179-0. Dermatol Ther (Heidelb). 2017. PMID: 28421455 Free PMC article. No abstract available.
17 results